Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun 1;11(4):469-81.
doi: 10.2174/187152712800792866.

Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease

Affiliations
Review

Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease

Guney Bademci et al. CNS Neurol Disord Drug Targets. .

Abstract

The tyrosine hydroxylase (TH) gene encodes a monoxygenase that catalyzes the rate limiting step in dopamine biosynthesis. A hallmark of Parkinson's disease (PD) is the loss of dopaminergic neurons in the substantia nigra. Consistent with the essential role of TH in dopamine homeostasis, missense mutations in both alleles of TH have been associated with severe Parkinsonism-related phenotypes including infantile Parkinsonism. It has been speculated for a long time that genetic variants in the TH gene modify adult-onset PD susceptibility but the answer has not been clear. Genetic variants (both sequence variations and structural variations) can be classified into three categories based on their relative frequency in population: common variants (polymorphisms), rare variants and mutations. Each of these factors has a different mode in influencing the genetic risk and often requires different approaches to decipher their contributions to the disease. In the past few years, the revolutionary advances in genomic technology have allowed systematic evaluations of these genetic variants in PD, such as the genome-wide association study (GWAS, to survey common variants), copy number variation analysis (to detect structural variations), and massive parallel next generation sequencing (to detect rare variants and mutations). In this review, we have summarized the latest evidence on TH genetic variants in PD, including our ongoing effort of using whole exome sequencing to search for rare variants in PD patients.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

Declared none.

Figures

Fig. 1
Fig. 1
Genomic variations in the TH gene. a) Display of the genomic variations in TH using the UCSC [50] genome browser (NCBI37/hg19). The “TH mutations” track displays the genomic position of disease causing missense, nonsense, frameshift and promoter region mutations as the vertical red line. The red horizontal bar displays the start and end position of the genomic deletions in TH reported by Bademci et al., 2010 and Ormazabal et al., 2011; b). Protein structure and missense/nonsense mutations in the TH protein. Point mutations are depicted with red arrows, phosphorylation sites of the serine residues activating the enzyme in the regulatory domain are depicted in blue ovals. The nomenclature of point mutation is based on the TH isoform 1 with 498 amino acids (NM_199292.2). Fig. (1b) is modified from Hufton et al. 1995[30]. (IBR=Intersubunit binding region)

Similar articles

Cited by

References

    1. Fahn S. Description of Parkinson’s disease as a clinical syndrome. Ann NY Acad Sci. 2003;991:1–14. - PubMed
    1. Hancock DB, Martin ER, Fujiwara K, Stacy MA, Scott BL, Stajich JM, Jewett R, Li YJ, Hauser MA, Vance JM, Scott WK. NOS2A and the modulating effect of cigarette smoking in Parkinson’s disease. Ann Neurol. 2006;60:366–373. - PubMed
    1. Li Y, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CA, Hulette C, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Welsh-Bohmer KA, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet. 2003;12:3259–3267. - PubMed
    1. Oliveira S, Li Y, XJQ, Zuchner S, Noureddine MA, Hauser MA, TS, SE, Pericak-Vance MA, JMV Novel genes associated with risk and age-at-onset in parkinson disease identified through iterative association mapping. American Society of Human Genetics; Toronto, Canada. October 26–30: 2004; 2005.
    1. Oliveira SA, Li YJ, Noureddine MA, Zuchner S, Qin X, Pericak-Vance MA, Vance JM. Identification of Risk and Age-at-Onset Genes on Chromosome 1p in Parkinson Disease. Am J Hum Genet. 2005;77:252–264. - PMC - PubMed

Publication types

MeSH terms

Substances